Drug Topics

DECEMBER 26, 2023

Biologic approvals ranged from gene therapies for hemophilia A to a cellular therapy to treat type 1 diabetes.

201

201

PhRMA

JUNE 8, 2023

Last week, I traveled to the American Society of Clinical Oncology’s (ASCO) annual meeting. It’s always an exceptional meeting where the brightest minds in oncology, including researchers, health care providers and industry stakeholders gather to learn about the latest advancements in cancer research and development (R&D).

206

206

Fierce Pharma

MARCH 15, 2024

Pfizer knew 2023 was going to be a challenging year of transition. But even the drugmaker was surprised by the plummeting demand for its COVID-19 products, missing badly on its 2023 guidance. million in 2023. . million in 2023.

145

145

Drug Topics

AUGUST 11, 2023

HHS awards money to fight the nursing shortage, the FDA approves Johnson & Johnson's talquetamab-tgvs (TALVEY), and the CDC says suicides reached an all-time high in 2022.

FDA 187

FDA 187

PhRMA

APRIL 26, 2023

Today PhRMA joins with innovators around the globe to recognize World IP Day and celebrate biopharmaceutical innovators who dedicate their lives to bringing new treatments and cures to patients.

235

235

Pharmacy Times

NOVEMBER 2, 2023

Pharmacy Times will be at the American Society for Nephrology’s (ASN) 2023 Kidney Week Annual Meeting in Philadelphia, Pennsylvania, from November 2 to 5.

149

149

Drug Topics

JUNE 15, 2023

Meet this year’s Pharmacy of the Year nominees and preview some of the sessions available at this year’s meeting.

186

186

STAT

DECEMBER 19, 2023

If David Ricks is the best biopharma CEO of 2023 , then Pfizer CEO Albert Bourla is, unfortunately, the worst. Pfizer is this year’s anti-Eli Lilly. My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability.

145

145

Fierce Healthcare

JULY 24, 2024

The Centers for Medicare & Medicaid Services (CMS) has released new data on risk adjustment payments for 2023. | The Centers for Medicare & Medicaid Services has released new data on risk adjustment payments for 2023.

Insurance 124

Insurance 124

STAT

SEPTEMBER 30, 2024

Health care stocks stumbled compared with the rest of the market in 2023. Even in a down year, the median health care CEO made 51 times the median American household income, which was around $81,000 in 2023. Companies missed their profit targets. Some CEOs even lost their bonuses. But the biggest names in health care still made $3.5

Pharmaceutical Companies 145

Pharmaceutical Companies Pharmaceutical Companies Hospitals Insurance 145

Fierce Healthcare

JUNE 12, 2024

National health spending is estimated to have outpaced the rest of the country’s economy in 2023, growing by 7.5% with projected expenditures of $4.8

Insurance Coverage 126

Insurance Coverage Insurance 126

PhRMA

JUNE 15, 2023

I always look forward to the American Society of Clinical Oncology’s Annual Meeting, which took place in Chicago earlier this month. It’s an opportunity for the world’s leading cancer experts to celebrate the latest innovations that are changing the treatment paradigm for patients with this disease.

222

222

Fierce Healthcare

OCTOBER 29, 2024

billion, the largest yearly savings in program history, in 2023, the Centers for Medicare & Medicaid Services revealed on Tuesday. billion, the largest yearly savings in program history, in 2023, the Centers for Medicare & Medicaid Services (CMS) revealed Oct. Accountable care organizations saved Medicare $2.1

131

131

Drug Topics

SEPTEMBER 30, 2023

As the Southern Hemisphere sees a mixed flu season, uncertainty looms for those in the North.

187

187

STAT

DECEMBER 18, 2023

Let’s get right to the main course: David Ricks of Eli Lilly is the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023. More on those high-achieving folks later. What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much.

141

141

STAT

DECEMBER 21, 2023

It’s the standard notice many health care organizations are required to provide when your protected health information gets exposed — and in 2023, data leaks, hacks, and mishandling led more of them to be delivered than ever before.

HIPAA 145

HIPAA 145

STAT

JULY 30, 2024

Rates of mental illness and substance use remained largely stable in 2023, according to federal data, underscoring the severity of the long-running U.S. mental health crisis and worst-in-the-world rates of illicit drug use. And while overall rates of nicotine use also remained roughly even, the way people consumed it shifted slightly.

136

136

Fierce Healthcare

MAY 23, 2024

in 2023, rebounding from a decline of 2.4% in 2023, rebounding from a decline of 2.4% After several years of modest or declining growth, the average pay for doctors jumped 5.9% After several years of modest or declining growth, the average pay for doctors jumped 5.9%

124

124

Pharmacy Times

OCTOBER 6, 2023

With World Standards Week on October 10 to 12, 2023, it is a key time to assess preparation for the official date for revised USP General Chapters and on compounding, as well as the associated USP General Chapter on the handling of hazardous drugs in healthcare settings.

Compounding 142

Compounding 142

STAT

OCTOBER 2, 2023

LONDON — Two pioneers of mRNA research — the technology that helped the world tame the virus behind the Covid-19 pandemic — won the 2023 Nobel Prize in medicine or physiology on Monday.

Immunization 145

Immunization Vaccines 145

Drug Topics

SEPTEMBER 7, 2022

Keep your pharmacy vaccine-ready for your youngest patients with the most current influenza vaccination information from the American Academy of Pediatrics.

Vaccines 201

Vaccines 201

Fierce Healthcare

APRIL 12, 2024

Any contentment about compensation gains was undercut by the effects of high inflation rates throughout 2023 and Medicare reimbursement cuts, according to Medscape's 2024 physician compensation report.

132

132

STAT

SEPTEMBER 15, 2023

After having missed multiple deadlines for ending polio transmission, the Global Polio Eradication Initiative had set 2023 as the year when both wild polio viruses would finally be snuffed out and so-called vaccine-derived viruses would also be stopped, putting an end to a family of viruses that have paralyzed children for centuries.

Vaccines 145

Vaccines 145

Drug Topics

NOVEMBER 29, 2023

This season marks the fourth to be classified as high severity since the 2009 influenza A(H1N1) pandemic.

187

187

Pharmacy Times

DECEMBER 14, 2023

The products include Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution, Icatibant Injection, Esomeprazole Magnesium Capsules, and Apremilast Tablets.

139

139

Fierce Pharma

NOVEMBER 6, 2024

Drugs for unmet needs and those from experienced companies had the best chance for successful launches in 2023: report kdunleavy Wed, 11/06/2024 - 09:23

115

115

Drug Topics

FEBRUARY 23, 2024

Manufacturer ARS Pharma will submit the data as part of a response to a CRL received in 2023.

232

232

STAT

DECEMBER 12, 2024

During 2023, drugmakers substantially raised prices on five widely used medicines without any new clinical evidence to justify the increases, leading patients and health insurers in the U.S. to spend an additional $815 million last year, according to a new report.

Insurance 125

Insurance 125

STAT

APRIL 10, 2024

The number of ongoing and active drug shortages in the U.S. stood at 323 during the fourth quarter of last year — the highest figure reached since such data began being tracked in 2001 — underscoring growing concerns about patient harm across the country.

Chemotherapy 142

Chemotherapy Immunization 142

Fierce Healthcare

FEBRUARY 12, 2024

Kaiser Permanente wrapped up its fiscal year with $329 million of operating income (0.3% operating income), net income of $4.1 billion and more than $100 billion in both operating revenues and expe | The California-based nonprofit noted cost pressures, labor challenges and membership declines but still logged a 0.3%

131

131

Drug Topics

MAY 13, 2024

Altuviiio was first granted approval by the FDA in February 2023.

Labelling 201

Labelling FDA 201

Drug Topics

DECEMBER 7, 2023

A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.

232

232

Drug Topics

JANUARY 8, 2024

Advocates can amplify the voices of transgender patients as they overcome barriers to health care, said Molly Crowther in a conversation at the 2023 Healthcare Advocate Summit.

198

198

Drug Topics

DECEMBER 7, 2023

Two posters presented at ASHP 2023 Midyear examined how accurate answers were from the artificial intelligence chatbot.

211

211

Fierce Pharma

DECEMBER 22, 2023

Even with the Federal Trade Commission keeping a watchful eye on the biopharma industry and the economic landscape giving some players pause, mergers and acquisitions are back on the rise.

140

140

Fierce Healthcare

JUNE 18, 2024

The uninsured rate in the U.S. has declined by 26% over the past several years, according to new data from the Centers for Disease Control and Prevention. | The uninsured rate in the U.S. has declined by 26% over the past several years, according to new data from the Centers for Disease Control and Prevention.

113

113

Drug Topics

NOVEMBER 8, 2023

The drug, Zepbound, will be available in the United States by the end of 2023.

FDA 201

FDA 201